Emory University Madrigal Pharmaceuticals, Inc. Transaction History

Emory University

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$84.4 - $106.53 $1.95 Million - $2.46 Million	-23,131 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$91.13 - $142.5 $501,123 - $783,607	5,499 Added 31.19%	23,131 $2.42 Million
Q1 2019 May 09, 2019	BUY	$103.48 - $143.84 $61,467 - $85,440	594 Added 3.49%	17,632 $2.21 Million
Q4 2018 Feb 12, 2019	BUY	$94.77 - $215.54 $1.61 Million - $3.67 Million	17,038 New	17,038 $1.92 Million

316

20M

824K

1.04M

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $4.86B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Emory University, based on Form 13F filings with the SEC.

Stay updated on Emory University with notifications on news.